弗雷明汉后代研究中预测的 25-羟维生素 D 评分与空腹血糖变化。
Predicted 25-hydroxyvitamin D score and change in fasting plasma glucose in the Framingham offspring study.
机构信息
Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA.
出版信息
Eur J Clin Nutr. 2012 Jan;66(1):139-41. doi: 10.1038/ejcn.2011.181. Epub 2011 Oct 19.
Data on the association between vitamin D status and actual change in glycemic measures are limited. We examined the prospective association between a predicted 25-hydroxyvitamin D (25(OH)D) score and change in fasting plasma glucose concentration over a mean follow-up of 7 years, in 2571 men and women (mean age 54 years) without diabetes in the Framingham Offspring Study cohort. After adjustment for age, sex, body mass index and fasting plasma glucose at baseline, higher predicted 25(OH)D score at baseline was associated with a smaller 7-year increase in fasting plasma glucose concentrations (0.23 mmol/l versus 0.35 mmol/l for highest versus lowest tertile of 25(OH)D score, respectively, P-trend=0.002). Vitamin D status may be an important determinant for change in fasting plasma glucose concentration among middle-aged and older adults without diabetes.
关于维生素 D 状态与血糖测量实际变化之间的关联的数据有限。我们在弗雷明汉后代研究队列中,检查了 2571 名无糖尿病的男性和女性(平均年龄 54 岁)中,预测的 25-羟维生素 D(25(OH)D)评分与空腹血浆葡萄糖浓度随时间变化的前瞻性关联,随访时间平均为 7 年。在调整年龄、性别、体重指数和基线时的空腹血浆葡萄糖后,基线时预测的 25(OH)D 评分较高与空腹血浆葡萄糖浓度 7 年增长率较低相关(最高与最低 25(OH)D 评分三分位组分别为 0.23mmol/l 与 0.35mmol/l,P 趋势=0.002)。维生素 D 状态可能是无糖尿病的中年及以上成年人空腹血浆葡萄糖浓度变化的一个重要决定因素。